Company Overview of BEXEL Pharmaceuticals, Inc.
BEXEL Pharmaceuticals, Inc. operates as a drug discovery pharmaceutical company. Its products include orally active small molecules for the treatment of chronic diseases, such as diabetes, inflammation, obesity, immunosuppresion, and cancer. The company was founded in 2002 and is based in Union City, California. BEXEL Pharmaceuticals, Inc. is a subsidiary of Orchid Chemicals & Pharmaceuticals Ltd.
32990 Alvarado Niles Road
Union City, CA 94587
Founded in 2002
Key Executives for BEXEL Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact BEXEL Pharmaceuticals, Inc., please visit www.bexelpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.